🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsDosing & ProtocolsDose escalation too fast? Recognizing over-titration symptoms — need advice

Dose escalation too fast? Recognizing over-titration symptoms — need advice

jennifer_SEA Sat, Dec 28, 2024 at 3:44 PM 12 replies 1,701 viewsPage 1 of 3
This thread is more than 17 months old. Information may be outdated. Consider searching for more recent discussions.
jennifer_SEA
Member
234
890
Nov 2024
Seattle, WA
Dec 28, 2024 at 3:44 PM#1

I titrated faster than the label because I felt fine, hit a wall at the third step, and had to come back down — which I now think was the predictable outcome rather than bad luck.

So the question, as narrowly as I can put it: what the trials actually did with participants who could not tolerate a step, because that is the situation I am in and the protocol summaries skip it.

Tell me what I have not thought of.

5 0lucas_SP_BR, lisa_labSD, adam_van and 2 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Dec 28, 2024 at 4:02 PM#2

Answering the narrow version, because the broad one does not have a single answer. Four weeks is the pharmacokinetics, not caution. With a one-week half-life you need four to five half-lives to reach steady state, so at two weeks you are dosing on top of a concentration that has not finished rising. Escalating then stacks exposure and you get the side-effect burden of the higher dose before you have seen the benefit of the current one.

Last edited: Dec 28, 2024 at 5:02 PM
4 24mike_nyc, VendorMark, COA_Karl and 1 other
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Dec 28, 2024 at 4:20 PM#3
DataDave said:
Four weeks is the pharmacokinetics, not caution.

That is right for the weekly injectables. For the daily agents the interval logic is different and the four-week convention does not transfer.

3 23COA_Karl, MikeFit_NJ, InsuranceTom
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
KarenAZ_mom
Member
567
2,567
Aug 2024
Scottsdale, AZ
Dec 28, 2024 at 4:38 PM#4
jennifer_SEA said:
I titrated faster than the label because I felt fine, hit a wall at the third step, and had to come back down — which I now think was the predictable…

This matches mine closely enough to be worth saying so. Holding longer is the underrated move. A step that is uncomfortable at week two is frequently comfortable at week six with no change in dose, because the gastric-emptying component tachyphylaxes while the appetite effect persists. Escalating at week two throws that adaptation away.

2 22LibrarianMeg, bri_stats
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Dec 28, 2024 at 6:16 PM#5

From the other side of the consultation, briefly.

Dose escalation anxiety for titration: I was terrified to move from 0.5mg to 1.0mg based on horror stories in this forum. But my actual experience? Slightly more appetite suppression, zero additional side effects.

Remember that the people posting about terrible side effects are a biased sample. Most people titrate up without drama — they just don't post about it because it's uneventful.

1 21carl_compliance
Reply Quote Save Share Report

Similar Threads

Micro-dosing semaglutide — is sub-therapeutic dosing effective?16 replies
Injection technique: subcutaneous depot formation and absorption8 replies
Semaglutide PK modeling — when to time your injection12 replies
Reconstitution calculator — compounded peptide dosing math7 replies
Half-life implications for missed doses — PK-based guidance5 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register